Successful treatment of aspergillus flavus spondylodiscitis with epidural abscess in a patient with chronic granulomatous disease

Pediatric Infectious Disease Journal

Volumn 31, Issue 1, 2012, Pages 100-101

  Chang, Hsien Mei ^a   Yu, Hsin Hui ^b   Yang, Yao Hsu ^b   Lee, Wen I ^c   Lee, Jyh Hong ^b   Wang, Li Chieh ^b   Lin, Yu Tsan ^b   Chiang, Bor Luen ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Aspergillus flavus; chronic granulomatous disease; spondylodiscitis

Indexed keywords

AMPHOTERICIN B; COTRIMOXAZOLE; HISTIDINE; ITRACONAZOLE; NITROBLUE TETRAZOLIUM; RECOMBINANT GAMMA INTERFERON; VORICONAZOLE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FLAVUS INFECTION; BONE BIOPSY; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; EPIDURAL ABSCESS; EXON; FUNGAL SINUSITIS; FUNGUS CULTURE; GENE DELETION; GENETIC ANALYSIS; GIEMSA STAIN; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; HYPERESTHESIA; INTERVERTEBRAL DISK DEGENERATION; KNEE PAIN; LOW BACK PAIN; MALE; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANASAL SINUSITIS; PATIENT COMPLIANCE; PERITONEAL DIALYSIS; PHAEOHYPHOMYCOSIS; PRIORITY JOURNAL; SUPERIOR CAVA VEIN SYNDROME;

ADOLESCENT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FLAVUS; DISCITIS; EPIDURAL ABSCESS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INTERFERON-GAMMA; LUMBAR VERTEBRAE; MALE; TREATMENT OUTCOME;

EID: 84855438605     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182309ec0     Document Type: Article

References (10)

1. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155-169. (Pubitemid 30327530)
2. van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4:e5234.
3. Segal BH, Romani LR. Invasive aspergillosis in chronic granulomatous disease. Med Mycol. 2009;47:S282-S290.
4. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327-360. (Pubitemid 351265310)
5. Gupta PK, Mahapatra AK, Gaind R, et al. Aspergillus spinal epidural abscess. Pediatr Neurosurg. 2001;35:18-23. (Pubitemid 32722315)
6. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med. 1991;324:509-516.
7. Ahlin A, Lärfars G, Elinder G, et al. Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils. Clin Diagn Lab Immunol. 1999;6:420-424. (Pubitemid 29226816)
8. Tsumura N, Akasu Y, Yamane H, et al. Aspergillus osteomyelitis in a child who has p67-phox-deficient chronic granulomatous disease. Kurume Med J. 1999;46:87-90. (Pubitemid 29254591)
9. Mouas H, Lutsar I, Dupont B, et al. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis. 2005; 40:1141-1147. (Pubitemid 40490239)
10. Horn D, Sae-Tia S, Neofytos D. Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry. Diagn Microbiol Infect Dis. 2009;63:384-387.